Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Atrial Fibrillation
Trial Locations (6)

10016

New York University School of Medicine, New York

10029

Icahn School of Medicine at Mount Sinai, New York

20246

University Heart Center Hamburg, Hamburg

52621

Sheba Medical Center, Ramat Gan

78075

Texas Cardiac Arrhythmia Research Foundation, Austin

Unknown

Royal Brompton & Harefield NHS Foundation Trust, London

Sponsors
All Listed Sponsors
lead

Itamar-Medical, Israel

INDUSTRY

NCT02129842 - Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation? | Biotech Hunter | Biotech Hunter